But that only scratches the surface of just how popular GLP-1 medications have become
The FDA warned against using salt forms as early as 2023 because they have different active ingredients than FDA-approved semaglutide
Studies have also found that BPC 157 can help protect against gastric ulcers caused by certain medications like nonsteroidal anti-inflammatory drugs (NSAIDs)
The patent landscape also discourages smaller manufacturers from entering the space
The SUSTAIN phase 3 clinical trials also demonstrated a significant reduction in the incidence of cardiovascular events compared to the current standard of care [2]
Studies have now examined BPC-157 in models of tendon injury, traumatic brain injury, peripheral nerve damage, cardiovascular stress, liver toxicity, kidney damage, and even mood regulation a scope that is extraordinary for a single research compound